Kamran Alam
Fortuna: 8 M $ al 31/05/2026
Fortuna: 8 M $ al 31/05/2026
Kamran Alam is currently Chief Financial Officer & Secretary at Taysha Gene Therapies, Inc. since 2020.
Former positions include Chief Financial Officer & Senior Vice President at Rocket Pharmaceuticals, Inc. from 2019 to 2020, Vice President-Finance at Novartis Gene Therapies, Inc. from 2016 to 2019, Senior Director-Finance & Accounting at Aptinyx, Inc. from 2013 to 2016, and Finance Director at Naurex, Inc. Education includes an undergraduate degree from Stephen M.
Ross School of Business and an MBA from Kelley School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 1.341.600 ( 0,49 % ) | 8 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Director Financiero/CFO | 01/08/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director Financiero/CFO | 01/07/2020 |
| AVEXIS INC | Corporate Officer/Principal | 01/10/2019 |
| APTINYX | Comptroller/Controller/Auditor | 01/04/2016 |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company, which develops novel therapies | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company, which develops novel therapies | Health Technology |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Aptinyx, Inc.
Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.